Central Garden & Pet/$CENT

1D1W1MYTD1Y5YMAX

About Central Garden & Pet

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.
Ticker
$CENT
Primary listing
NASDAQ
Employees
5,850

CENT Metrics

BasicAdvanced
$2.2B
15.01
$2.67
0.54
-

What the Analysts think about CENT

Analyst ratings (Buy, Hold, Sell) for Central Garden & Pet stock.
Analyst projections of the future price of Central Garden & Pet stock.

Bulls say / Bears say

Central’s strategic pet distribution joint venture with Phillips Pet Food & Supplies allows it to retain a 20% ownership stake while offloading lower-margin distribution operations, freeing up capital to reinvest in higher-growth, higher-margin core brands. (Reuters)
Following Q3 FY 2026 results, Central raised its fiscal 2026 non-GAAP EPS outlook to at least $2.85 per share, signaling strong confidence in underlying margin expansion and operational leverage. (Reuters)
The definitive agreement to acquire an 80% stake in TRIXIE for up to €400 million significantly expands Central’s presence in Europe’s €10 billion pet supplies market and diversifies its international revenue base. (Reuters)
GAAP EPS in Q3 FY 2026 declined to $1.45 from $1.52 a year earlier, marking a 5% drop in profitability. (Reuters)
Q3 net sales missed analyst estimates, falling 8% to $882 million due to the exit of its pet distribution business, underscoring near-term revenue headwinds. (Reuters)
The planned acquisition of TRIXIE is contingent on regulatory approval and customary closing conditions, introducing execution risk that could delay expected strategic benefits. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 24 Aug 2026.

CENT Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

CENT Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.